VULNERABILITY INTELLIGENCE

CVE-2017-17678

CVSS score6.1 MEDIUM

EPSS probability0.59%

CISA KEVNot currently listed

Published2021-05-19

Last modified2026-07-09

CVSS vectorCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Description

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

Weakness classification

CWE-79: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')

Primary references

cve@mitre.org — Release Notes, Vendor Advisory
cve@mitre.org — Mailing List, Third Party Advisory
af854a3a-2127-422b-91ae-364da2661108 — Release Notes, Vendor Advisory
af854a3a-2127-422b-91ae-364da2661108 — Mailing List, Third Party Advisory